- In September 2022, RxCap, Inc. partnered with ZEPHYRx to integrate ZEPHYRx's online spirometry platform with RxCap's remote surveillance system. This collaboration enables RxCap's corporate clients, including healthcare providers and insurers, to monitor the lung health of patients with severe respiratory diseases remotely
- In August 2022, AstraZeneca collaborated with Alveofit to deploy IoT-enabled portable spirometers in U.S. clinics. These handheld devices connect to the internet, enabling online patient tracking and tele-spirometry. Integrated with comprehensive care management systems, they enhance respiratory care accessibility and efficiency
- In November 2021, Cipla launched Spirofy, India's first pneumotach-based portable, wireless spirometer, on World Chronic Obstructive Pulmonary Disease (COPD) Day. This launch is set to significantly impact the spirometer market in India, aiming to transform the diagnosis of Obstructive Airway Disease (OAD) and reinforcing Cipla's ambition to solidify its leadership in the country's respiratory care sector. The introduction of this innovative device is expected to increase the accessibility and efficiency of OAD diagnosis, further driving demand for advanced spirometry solutions in the region
- In April 2021, Vitalograph launched the next-generation Pneumotrac spirometer in the U.S. This device, paired with Spirotrac PC software, is designed for precise respiratory diagnosis in both adult and pediatric patients, enhancing diagnostic capabilities and clinical management in respiratory healthcare
